ADC Digest – August 2020 ADC Digest – August 2020 Kadcyla approved in Japan for adjuvant therapy of HER2-positive early breast cancer 21 Aug 2020 Kadcyla (Trastuzumab emtansine, Tubulin polymerization inhibitor; Chugai (a Roche subsidiary)/Immunogen) Approval was based on the […]